Discover
DYN
Dyne Therapeutics, Inc.
21.79
2 x 16.07
2 x 28.08
bid
ask
-
0.42
1.89%
2 @ 04:00 PM
21.79 +0.00 (0.00%)
| Ytd | 11.40% | |
| 1y | 151.04% |
21.70
day range
22.44
8.06
52 week range
25.00
| Open | 22.15 | Prev Close | 22.21 | Low | 21.70 | High | 22.44 | Mkt Cap | 3.60B |
| Vol | 1.33M | Avg Vol | 1.79M | EPS | -3.15 | P/E | N/A | Forward P/E | -7.28 |
| Beta | 1.08 | Short Ratio | 14.55 | Inst. Own | 115.51% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 07-27 | 50-d Avg | 18.51 | 200-d Avg | 17.97 | 1yr Est | 38.25 |
DYN News
fool.com
Dyne Therapeutics vs. Vertex Pharmaceuticals: Which Drug Innovator Stock Is a Better Buy in 2026?
Dyne Therapeutics focuses on high-potential therapies for rare neuromuscular diseases using its prop
fool.com
Dyne Therapeutics vs. Viking Therapeutics: Which Healthcare Stock Is a Better Buy in 2026?
Dyne is advancing therapies for rare muscle diseases while Viking targets the booming weight-loss ma
etftrends.com
Biotech ETF Index Surges 10% After Rebalance
After a sweeping semi-annual rebalance, the biotech index underlying the ALPS Medical Breakthroughs
benzinga.com
Dyne Therapeutics Completes Enrollment In Registrational Expansion Cohort Of Phase 1/2 ACHIEVE Trial
- Registrational expansion cohort enrolled 71 participants; topline data planned for Q1 2027 - WALTH